聚乙二醇干扰素-α治疗肝移植后慢性戊型肝炎病毒感染。
Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.
机构信息
Department of Nephrology, Dialysis and Organ Transplantation, Centre Hospitalier Universitaire, Toulouse, France.
出版信息
Clin Infect Dis. 2010 Mar 1;50(5):e30-3. doi: 10.1086/650488.
DOI:10.1086/650488
PMID:20113176
Abstract
This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.
摘要
本研究评估了 3 例慢性活动性戊型肝炎肝移植患者接受 3 个月聚乙二醇干扰素-α-2a（Peg-IFN-α-2a）治疗的效果。2 例患者在完成 Peg-IFN-α-2a 治疗后 6 个月和 5 个月时持续出现病毒学应答。第 3 例患者出现复发。
Zotero 插件